Appearance: | WHITE POWDER |
---|---|
Brand Name: | luspharm |
Purity: | 99%HPLC |
Type: | API |
CAS No.: | 434-07-1 |
Application: | API |
Model Number: | LUSAPI2240 |
Place of Origin: | China (Mainland) |
MF: | C21H32O3 |
Other Names: | 17-alpha-Methyl-2-hydroxymethylene-17-hydroxy-5-alpha-androstan-3-one; |
MW: | 332.48 |
Quick Details
Specifications
Product Number | LUSAPI2240 |
Product name | Oxymetholone |
CAS NO. | 434-07-1 |
English Alias | 17-alpha-Methyl-2-hydroxymethylene-17-hydroxy-5-alpha-androstan-3-one; |
Specification | 99% HPLC |
Molecular Formula | C21H32O3 |
Molecular Weight | 332.48 |
Appearance | White powder |
Package | According to the clients requirements |
Hebei Luspharm Trading Co., Ltd. Is a high-tech enterprise engages in manufacturing and marketing chemicals for international distribution,specialized in APIs, advanced intermediates, botanical extract and color industry.
Our goal is becoming leading position in global distribution and trading based on unique combination of technical skill,unrivaled supplier network, market knowledge and an absolute commitment to customer satisfaction.
under a management team with professional experiences in chemical development, a pathbreaking optimization in our R&D center,advanced multi-purpose manufacturing facility and large-scale production line with GMP workshop, we can supply finished synthesis as client requirements and be sure high quality products,low costs, adequate supply and integrated excellent services.
Luspharm headquarters are located in Shijiazhuang, China. Hebei Luspharm Trading Co., Ltd. Is in charge of all business of Luspharm.
Our mission and enthusiasm is introducing the high quality Chinese ingredients to global customers, and becoming a bridge between the changing China and the changing needs of our clients.Focus, then the best".
Adhering to the tenet of "today's quality will open up tomorrow's market", insisting on the philosophy of "integrity, win-win", we would like to cooperate with friends at home and abroad for creating bright future.